Back to overview

Team Ventures

Triplebar Bio

Year of investment: 2023

Food & Agri

Early stage

Ventures

Active

USA

Triplebar Bio uses high-throughput screening to optimize microbial strains, cell lines and antibodies for partners developing food, nutrition and healthcare products.

A partnership built for impact

Our investment helps lower the cost and time required to develop products made through precision fermentation and cell-based production, supporting partners in commercializing more sustainable proteins, ingredients and biologics.

“Biomanufacturing has enormous potential, but the industry needs better tools to improve speed, cost, and reliability. TripleBar’s platform can screen biology at a scale that was previously impractical, enabling faster development of proteins, cell lines, enzymes, and other bio-based products. We believe this is an important enabling technology for the next generation of sustainable food and biotechnology.”

— Katrien Swerts, Executive Director at Rabo Investments